New Strategies to Assess Anal Cancer Risk In Women
NCT02873741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143
Last updated 2019-11-06
Summary
The purpose of this research is to study different strategies to identify women at highest risk for anal cancer. Primarily, investigators want to study a risk assessment called the Anal Cancer Risk Index; it gives women an overall number score based on risk factors that they may have for anal cancer, such as age, number of sexual partners, or smoking. Investigators seek to understand whether women with higher Anal Cancer Risk Index scores are more likely to have abnormal results on anal pap smears, HPV tests, or anal biopsies. The study team will collect swabs of the cervix and the anus to study different laboratory tests that could identify women at highest risk of cervical and anal cancer. These laboratory tests include an anal pap smear, tests for markers of disease and tests that detect the HPV types most likely to cause cancer. The study team would like to see which of these laboratory tests do the best job at predicting precancerous lesions in the anus and are better indicators of risk for cancer. After collecting these swabs, women will have a procedure called high resolution anoscopy where investigators look closely at the anus and biopsy any suspicious areas. Finally, the study team will look for HPV proteins and changes that HPV can make in cells to see if these tests predict anal lesions.
Conditions
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
Interventions
- PROCEDURE
-
Perianal and Digital Anorectal Exam
The physician will inspect the outside of the anus and use a gloved finger to feel the anus for any masses.
- PROCEDURE
-
Cervical Swabs
A speculum will be inserted into the vagina to visualize the cervix. The sample for research tests will be collected with one ThinPrep cytobroom inserted into the cervix. Collection will be same for the sample to be paced in the RNA storage solution for future biomarker studies.
- PROCEDURE
-
Anal Swabs
The anal cytology specimen will be collected by inserting a saline moistened cotton-tipped swab into the anus, rotating it clock-wise for 20 seconds, and placed in SurePath. The first twenty participants will have anal cells collected in two different ways for validation/optimization: 1) saline moistened Dacron swab placed directly in ThinPrep medium and 2) Medscand Cytobrush Plus, a special brush, placed directly into ThinPrep medium. After validation/optimization is complete for up to 20 participants, the best collection method will be selected and will be used for all future enrolled participants.
- PROCEDURE
-
High Resolution Anoscopy (HRA)
High Resolution Anoscopy is a procedure that allows for examination and evaluation of the anal canal. Using a small thin round tube called an anoscope, the anal canal is examined with a high resolution magnifying instrument called a colposcope. Application of a mild acidic liquid (acetic acid or diluted vinegar) or a brown iodine-based solution (Lugol's) onto the anal canal facilitates evaluation of abnormal tissue such as anal dysplasia. If abnormal staining is seen using acetic acid (dense white lesion) or Lugol's solution (bright yellow lesion) a biopsy of that area will be obtained.
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Lisa Flowers, MD · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2017-02-27
- Completion
- 2017-02-27
Countries
- United States
Study Locations
More Related Trials
-
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
NCT06574087 ·Status: RECRUITING ·Phase: NA
-
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
NCT02140021 ·Status: TERMINATED ·Phase: NA
-
Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
NCT03241680 ·Status: UNKNOWN ·Phase: NA
-
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
NCT06327568 ·Status: RECRUITING
-
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
NCT01313104 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women
NCT03789513 ·Status: UNKNOWN ·Phase: NA
-
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
NCT05870787 ·Status: COMPLETED
-
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
NCT02956031 ·Status: RECRUITING
-
Overlooked Population at Risk for AIN.
NCT01953094 ·Status: COMPLETED ·Phase: NA
-
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico
NCT05074264 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon
NCT07181278 ·Status: RECRUITING ·Phase: NA
-
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
NCT05413811 ·Status: COMPLETED ·Phase: NA
-
HPV Infection and Vaginal Microecology in Immunosuppressed Women
NCT06619743 ·Status: NOT_YET_RECRUITING
-
HRME in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)
NCT03195218 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
NCT06522256 ·Status: RECRUITING ·Phase: NA
-
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
NCT01605656 ·Status: COMPLETED
-
The Women's Screening and Self-Testing Program (PROMETA) Study
NCT06810739 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detecting HPV DNA in Anal and Cervical Cancers
NCT04857528 ·Status: RECRUITING
-
HPV Self-testing in Transgender Individuals
NCT05883111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
NCT06971276 ·Status: COMPLETED
-
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
NCT07214584 ·Status: RECRUITING
-
HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
NCT05981807 ·Status: UNKNOWN
-
HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings
NCT02494310 ·Status: COMPLETED ·Phase: NA
-
Characterization of Immunosuppressive Signing of Cervical Cancer
NCT02875990 ·Status: UNKNOWN ·Phase: NA